• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对家族性癌症的临床遗传咨询需要有关家族性癌症风险的可靠数据和总体行动计划。

Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans.

作者信息

Hemminki K, Eng C

机构信息

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.

出版信息

J Med Genet. 2004 Nov;41(11):801-7. doi: 10.1136/jmg.2004.022731.

DOI:10.1136/jmg.2004.022731
PMID:15520403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1735611/
Abstract

Familial cancer clustering, without obvious heritability, poses a major challenge for current cancer risk assessment and management. Reliable determination of familial risks for cancer is important for clinical genetic counselling, but medically verified data on familial risks for many malignancies have been limited. However, the nationwide Swedish Family-Cancer Database allows a reliable characterisation of familial risk for all major neoplasms. Even though alert genetic counsellors and certainly clinical cancer geneticists will consider familial cancer clustering in their purview, the standard medical referral systems, which have already been shown to be poor in capturing and referring families at high risk for heritable cancers, are unlikely to ascertain familial aggregations of other cancers that are not known to belong to an inherited cancer syndrome. The data will be helpful in implementing evidence based guidelines for helping the general medical system to ascertain and refer even familial cancer clusters to cancer genetics professionals.

摘要

家族性癌症聚集现象,在没有明显遗传力的情况下,给当前的癌症风险评估和管理带来了重大挑战。准确确定癌症的家族风险对于临床遗传咨询很重要,但许多恶性肿瘤家族风险的医学验证数据一直有限。然而,瑞典全国性的家族癌症数据库能够可靠地描述所有主要肿瘤的家族风险。尽管警惕的遗传咨询师以及临床癌症遗传学家肯定会将家族性癌症聚集纳入他们的工作范围,但标准的医疗转诊系统在识别和转诊遗传性癌症高危家庭方面已被证明效果不佳,不太可能确定其他不属于遗传性癌症综合征的癌症的家族聚集情况。这些数据将有助于实施基于证据的指南,以帮助普通医疗系统识别甚至将家族性癌症聚集转诊给癌症遗传学专业人员。

相似文献

1
Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans.针对家族性癌症的临床遗传咨询需要有关家族性癌症风险的可靠数据和总体行动计划。
J Med Genet. 2004 Nov;41(11):801-7. doi: 10.1136/jmg.2004.022731.
2
Familial risks for cancer as the basis for evidence-based clinical referral and counseling.作为循证临床转诊和咨询依据的癌症家族风险。
Oncologist. 2008 Mar;13(3):239-47. doi: 10.1634/theoncologist.2007-0242.
3
Familial risk of cancer: data for clinical counseling and cancer genetics.癌症的家族风险:临床咨询与癌症遗传学数据
Int J Cancer. 2004 Jan 1;108(1):109-14. doi: 10.1002/ijc.11478.
4
Familial risk of urological cancers: data for clinical counseling.泌尿系统癌症的家族风险:临床咨询数据。
World J Urol. 2004 Feb;21(6):377-81. doi: 10.1007/s00345-003-0375-7. Epub 2003 Nov 13.
5
Genetic epidemiology of cancer: from families to heritable genes.癌症的遗传流行病学:从家族到可遗传基因
Int J Cancer. 2004 Oct 10;111(6):944-50. doi: 10.1002/ijc.20355.
6
Genetic testing for cancer predisposition.癌症易感性的基因检测。
Annu Rev Med. 2001;52:371-400. doi: 10.1146/annurev.med.52.1.371.
7
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
8
Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes.遗传性胃肠癌综合征中的遗传咨询与基因检测
Best Pract Res Clin Gastroenterol. 2009;23(2):275-83. doi: 10.1016/j.bpg.2009.02.009.
9
Can we identify the high-risk patients to be screened? A genetic approach.我们能否识别出需要筛查的高危患者?一种遗传学方法。
Digestion. 2007;76(1):7-19. doi: 10.1159/000108389. Epub 2007 Oct 19.
10
Familial association of prostate cancer with other cancers in the Swedish Family-Cancer Database.瑞典家族癌症数据库中前列腺癌与其他癌症的家族关联。
Prostate. 2005 Oct 1;65(2):188-94. doi: 10.1002/pros.20284.

引用本文的文献

1
Are population level familial risks and germline genetics meeting each other?人群层面的家族风险与种系遗传学是否相互契合?
Hered Cancer Clin Pract. 2023 Mar 8;21(1):3. doi: 10.1186/s13053-023-00247-3.
2
Familial Risks and Proportions Describing Population Landscape of Familial Cancer.家族性风险以及描述家族性癌症人群格局的比例。
Cancers (Basel). 2021 Aug 30;13(17):4385. doi: 10.3390/cancers13174385.
3
Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.对 153115 例血液系统恶性肿瘤患者的分析细化了家族性风险谱。
Blood. 2019 Sep 19;134(12):960-969. doi: 10.1182/blood.2019001362. Epub 2019 Aug 8.
4
Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms.急性髓系白血病、骨髓增生异常综合征和骨髓增殖性肿瘤的家族风险。
Blood. 2018 Aug 30;132(9):973-976. doi: 10.1182/blood-2018-06-858597. Epub 2018 Jul 10.
5
The recurrence risk of genetic complex diseases.遗传性复杂疾病的复发风险。
J Res Med Sci. 2017 Mar 15;22:32. doi: 10.4103/1735-1995.202143. eCollection 2017.
6
Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions.中国结直肠癌前病变人群中KRAS和BRAF突变的临床病理分布
Oncotarget. 2016 Mar 29;7(13):17265-74. doi: 10.18632/oncotarget.7504.
7
Adenomatous polyposis coli genotype-dependent toll-like receptor 4 activity in colon cancer.结肠癌中腺瘤性息肉病 coli 基因型依赖性 Toll 样受体 4 活性
Oncotarget. 2016 Feb 16;7(7):7761-72. doi: 10.18632/oncotarget.6844.
8
Population Landscape of Familial Cancer.家族性癌症的人群概况
Sci Rep. 2015 Aug 10;5:12891. doi: 10.1038/srep12891.
9
Personalized medicine: caught between hope, hype and the real world.个性化医学:在希望、炒作与现实世界之间徘徊。
Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):91-7. doi: 10.6061/clinics/2012(sup01)16.
10
Familial risks in nervous system tumours: joint Nordic study.神经系统肿瘤的家族风险:北欧联合研究。
Br J Cancer. 2010 Jun 8;102(12):1786-90. doi: 10.1038/sj.bjc.6605708. Epub 2010 May 25.

本文引用的文献

1
A breast cancer prediction model incorporating familial and personal risk factors.一种纳入家族和个人风险因素的乳腺癌预测模型。
Stat Med. 2004 Apr 15;23(7):1111-30. doi: 10.1002/sim.1668.
2
Referral for cancer genetics consultation: a review and compilation of risk assessment criteria.癌症遗传学咨询转诊:风险评估标准的综述与汇编
J Med Genet. 2004 Feb;41(2):81-91. doi: 10.1136/jmg.2003.010918.
3
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.家族病史评估与筛查项目中乳腺癌风险评估套餐的评估
J Med Genet. 2003 Nov;40(11):807-14. doi: 10.1136/jmg.40.11.807.
4
Familial risk of cancer: data for clinical counseling and cancer genetics.癌症的家族风险:临床咨询与癌症遗传学数据
Int J Cancer. 2004 Jan 1;108(1):109-14. doi: 10.1002/ijc.11478.
5
Family history of colorectal cancer in a Sweden county.
Fam Cancer. 2003;2(2):87-93. doi: 10.1023/a:1025734200635.
6
Use of fear-appeal techniques in the design of tailored cancer risk communication messages: implications for healthcare providers.在定制癌症风险沟通信息设计中运用恐惧诉求技巧:对医疗服务提供者的启示
J Clin Oncol. 2003 Sep 1;21(17):3375-6. doi: 10.1200/JCO.2003.99.049.
7
Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.美国遗传性非息肉病性结直肠癌的分子分析:临床选择家族中的高突变检出率及MSH2基因一个美国奠基者基因组缺失的特征分析
Am J Hum Genet. 2003 May;72(5):1088-100. doi: 10.1086/373963. Epub 2003 Mar 25.
8
Hereditary colorectal cancer.遗传性结直肠癌
N Engl J Med. 2003 Mar 6;348(10):919-32. doi: 10.1056/NEJMra012242.
9
Familial and second lung cancers: a nation-wide epidemiologic study from Sweden.家族性和继发性肺癌:一项来自瑞典的全国性流行病学研究。
Lung Cancer. 2003 Mar;39(3):255-63. doi: 10.1016/s0169-5002(02)00535-4.
10
Breast cancer risk assessment models: applicability to African-American women.乳腺癌风险评估模型:对非裔美国女性的适用性。
Cancer. 2003 Jan 1;97(1 Suppl):230-5. doi: 10.1002/cncr.11018.